Eli Lilly Works with OpenAI to Find Novel Medicines to Treat Drug-Resistant Bacteria
Photo: Unsplash in collaboration with Getty Images. By Christina Phillips Eli Lilly and Company announced a collaboration with OpenAI that will allow Lilly to leverage OpenAI’s generative AI to invent novel antimicrobials to treat drug-resistant pathogens. In a news release on June 25, Lilly said antimicrobial resistance (AMR) is one of the top public health … More Eli Lilly Works with OpenAI to Find Novel Medicines to Treat Drug-Resistant Bacteria